The emerging therapy of this peptide represents a exciting breakthrough in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – leading https://tirzepatide-peptide882587.rimmablog.com/40708994/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment